News and Press Releases
Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI
BILLERICA, Mass. - June 8, 2026 - Bruker Corporation announced the commissioning of a novel BioSpec™ 18 Tesla preclinical MRI, the world’s highest-field horizontal-bore MRI system, at the Champalimaud Foundation...
Category:
Posted: June 8, 2026
Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026
WALTHAM, Mass, US: Thermo Fisher Scientific Inc., the world leader in serving science, today expanded its suite of Thermo Scientific™ Orbitrap™ mass spectrometry platforms, AI-enabled software and integrated workflows at...
Category:
Posted: June 3, 2026
ThermoSafe Expands US Based VIP Manufacturing to Strengthen Cold Chain Supply Assurance for Life Sciences Customers
Arlington Height, IL, US, May 26, 2026: ThermoSafe, a global leader in temperature-controlled packaging technologies, today announced a significant expansion of its US based manufacturing capabilities for Vacuum Insulated Panels...
Category:
Posted: June 3, 2026
Johnson & Johnson has received CE mark approvals for CEREGLIDE 42 and CEREGLIDE 57. Together with CEREGLIDE 71 and INNERGLIDE 7 delivery aid, these additions expand Johnson & Johnson MedTech Stroke Solutions Portfolio in EMEA
“We designed this multi-axial system to address procedural challenges physicians face when treating stroke,” said Christian Cuzick, Worldwide President, Neurovascular, MedTech, Johnson & Johnson. “With this expanded portfolio, we’re simplifying...
Category:
Posted: June 3, 2026
uMotif Announces Andrea Valente is Chief Executive Officer
BOSTON and LONDON, June 1, 2026 -- uMotif – one of the fastest-growing companies in the clinical trial technology market – announces Andrea Valente is now Chief Executive Officer, effective today. Valente takes over from...
Category:
Posted: June 1, 2026
Machine Learning Maps and Discovers Clinical Endpoints in Pompe Disease Using Real-World Data
In the largest machine learning study of Pompe disease to date, Volv Global demonstrates that clinician-defined endpoints can be tracked and novel disease features discovered in US claims data across...
Category:
Posted: June 1, 2026
Vetter Achieves Platinum Status as a Best Managed Company
Ravensburg, May 26, 2026: Vetter, a leading Contract Development and Manufacturing Organization (CDMO), has been named a Best Managed Company for the seventh year in a row. The family-owned business...
Category:
Posted: May 26, 2026
PADCEVTM (enfortumab vedotin) in Combination with Keytruda (pembrolizumab) Receives Positive CHMP Opinion for the Treatment of Patients with Resectable Muscle-Invasive Bladder Cancer who are Ineligible for Cisplatin-Based Chemotherapy
Positive opinion is based on data from the pivotal Phase 3 EV-303 trial showing a 60% reduction in the risk of disease recurrence, progression or death and a 50% reduction...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 22, 2026
STORM Therapeutics to Present Promising Phase 1 Sarcoma Data Demonstrating Activity of First‑in‑Class METTL3 Inhibitor STC‑15 at ASCO 2026
Subset analysis shows early clinical activity supported by biomarker evidence of targeting cancer stem cell pathways driving tumor growth and progression 22 May 2026 -- Cambridge, UK -- STORM Therapeutics, the...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 22, 2026
Pivotal trial data for EP0031 (A400), a next-generation Selective RET Inhibitor (SRI), in RET positive advanced NSCLC, to be presented at ASCO 2026
22 May 2026 -- London, UK -- Ellipses Pharma, a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 22, 2026
HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE (Fruquintinib) in Combination with TYVYT (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma
Reduced risk of disease progression or death by 63%, with median PFS of 22.2 months in the FRUSICA-2 registration study 21 May 2026 -- Hong Kong, Shanghai and New Jersey,...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: May 21, 2026
Otsuka Pharmaceuticals UK announces MHRA authorisation of new treatment option for the routine prevention of recurrent attacks of hereditary angioedema in adults and adolescents aged 12 years and older
The first ribonucleic acid (RNA)-targeted prophylactic therapy for patients with hereditary angioedema (HAE) to be authorised by the MHRA HAE is a rare and potentially life-threatening genetic condition affecting approximately...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 21, 2026
Gallions Wexham Springs Framewood Road Wexham SL3 6PJ
Almac Group delivers record year of growth
Almac Group, the global contract pharmaceutical development and manufacturing organisation, has announced record financial results for the year ending 30 September 2025, with revenue, profit and employee numbers all reaching...
Category:
Posted: May 21, 2026
Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis
UK NHS grants HRA/REC approval for PEMP study with Peterborough and Cambridge hospitals Clinical observational study investigating underlying biology of endometriosis aims to uncover causal mechanisms and new druggable targets...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 19, 2026
Mestag Therapeutics Announces the First Patient Dosed with MST-0312 in the Phase I STARLYS Trial
STARLYS trial to evaluate the potential of MST-0312, a targeted lymphotoxin-beta (LTBR) agonist bispecific antibody, as a novel therapeutic strategy for the treatment of solid tumors Study to evaluate tertiary...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 19, 2026
Suite 15 Science Village, Chesterford Research Park, Little Chesterford, Cambridge, CB10 1XL UK
